XML 20 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Income Statements - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]      
Gross Sales $ 514,997 $ 525,936 $ 491,538
Commissions, allowances and rebates 1,018 1,995 2,369
Net sales 513,979 523,941 489,169
Other revenues, net 18,114 10,515 1,475
Net revenue 532,093 534,456 490,644
Cost of goods sold 335,405 304,153 286,256
Gross profit 196,688 230,303 204,388
Selling, general and administrative expenses 68,506 68,984 58,042
Research and development expenses 15,547 16,901 14,292
Acquisition and integration expenses 11,139   840
Restructuring expenses     1,158
Operating expenses 95,192 85,885 74,332
Operating profit 101,496 144,418 130,056
Other expenses/(income)      
Interest expense, net 3,967 1,253 717
Unrealized gain on investment in equity securities (13,023)    
Other expenses, net 747 1,340 1,800
Income before income taxes 109,805 141,825 127,539
Provision for income taxes 16,596 38,061 40,214
Income from continuing operations 93,209 103,764 87,325
Loss from discontinued operations, net of tax (791) (1,314) (5,647)
Net income $ 92,418 $ 102,450 $ 81,678
Basic earnings per share      
Income from continuing operations $ 2.80 $ 3.18 $ 2.72
Loss from discontinued operations, net of tax (0.02) (0.04) (0.17)
Net income 2.78 3.14 2.55
Diluted earnings per share      
Income from continuing operations 2.77 3.10 2.65
Loss from discontinued operations, net of tax (0.02) (0.04) (0.17)
Net income $ 2.75 $ 3.06 $ 2.48
Weighted average shares outstanding:      
Basic weighted average shares outstanding 33,243 32,662 32,086
Effect of dilutive stock based compensation 422 824 883
Diluted weighted average shares outstanding 33,665 33,486 32,969